Chun‐Hwei Tai

3.1k total citations
80 papers, 2.2k citations indexed

About

Chun‐Hwei Tai is a scholar working on Neurology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Chun‐Hwei Tai has authored 80 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Neurology, 33 papers in Cellular and Molecular Neuroscience and 11 papers in Molecular Biology. Recurrent topics in Chun‐Hwei Tai's work include Parkinson's Disease Mechanisms and Treatments (47 papers), Neurological disorders and treatments (37 papers) and Genetic Neurodegenerative Diseases (19 papers). Chun‐Hwei Tai is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (47 papers), Neurological disorders and treatments (37 papers) and Genetic Neurodegenerative Diseases (19 papers). Chun‐Hwei Tai collaborates with scholars based in Taiwan, United States and Canada. Chun‐Hwei Tai's co-authors include Ruey‐Meei Wu, Chin‐Hsien Lin, Sheng‐Hong Tseng, Wuh‐Liang Hwu, Ni‐Chung Lee, Yin‐Hsiu Chien, Barry J. Byrne, Shin‐ichi Muramatsu, Sheau‐Ling Huang and Ching‐Lin Hsieh and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Neuroscience and SHILAP Revista de lepidopterología.

In The Last Decade

Chun‐Hwei Tai

78 papers receiving 2.2k citations

Peers

Countries citing papers authored by Chun‐Hwei Tai

Since Specialization

Citations

This map shows the geographic impact of Chun‐Hwei Tai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chun‐Hwei Tai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chun‐Hwei Tai more than expected).

Fields of papers citing papers by Chun‐Hwei Tai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chun‐Hwei Tai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chun‐Hwei Tai. The network helps show where Chun‐Hwei Tai may publish in the future.

Co-authorship network of co-authors of Chun‐Hwei Tai

This figure shows the co-authorship network connecting the top 25 collaborators of Chun‐Hwei Tai. A scholar is included among the top collaborators of Chun‐Hwei Tai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chun‐Hwei Tai. Chun‐Hwei Tai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Biodegradable, electroconductive self-healing hydrogel based on polydopamine-coated polyurethane nano-crosslinker for Parkinson's disease therapy 2025 ·Biomaterials ·Tsai‐Yu Chen, Junpeng Xu, Chun‐Hwei Tai, (unknown), Shan‐hui Hsu	2
2	Influence of Verbal Instruction on Gait Training in Parkinson Disease: A Randomized Controlled Trial 2024 ·American Journal of Physical Medicine & Rehabilitation ·(unknown), Chun‐Hwei Tai, Jer-Junn Luh, Yu-Jen Chen, Wei‐Li Hsu, Ya‐Yun Lee	1
3	The responses of subthalamic beta oscillations during voluntary movement in patients with Parkinson’s disease 2024 ·Chun‐Hwei Tai, (unknown), (unknown), Ruey‐Meei Wu, Chia‐Jung Hsieh, Sheng-Hong Tseng	1
4	Advanced brain aging in Parkinson’s disease with cognitive impairment 2024 ·npj Parkinson s Disease ·Chang‐Le Chen, (unknown), Leila Montaser‐Kouhsari, Wenchao Wu, Yung‐Chin Hsu, Chun‐Hwei Tai, Wen‐Yih Isaac Tseng, Ming‐Che Kuo, Ruey‐Meei Wu	6
5	Bioactive self-healing hydrogel based on tannic acid modified gold nano-crosslinker as an injectable brain implant for treating Parkinson’s disease 2023 ·Biomaterials Research ·Junpeng Xu, Tsai‐Yu Chen, Chun‐Hwei Tai, Shan‐hui Hsu	36
6	Training in Varying Environmental Contexts Facilitates Transfer of Improved Gait Performance to New Contexts for Individuals With Parkinson Disease: A Randomized Controlled Trial 2022 ·Archives of Physical Medicine and Rehabilitation ·Ya‐Yun Lee, Chun‐Hwei Tai, Beth E. Fisher	5
7	Long-Term Outcomes of Idiopathic and Acquired Dystonia After Pallidal Deep Brain Stimulation: A Case Series 2022 ·World Neurosurgery ·Chun‐Hwei Tai, (unknown), Chin‐Hsien Lin, Wang‐Tso Lee, Ruey‐Meei Wu, Sheng‐Hong Tseng	4
8	Generation of a human induced pluripotent stem cell (iPSC) line (IBMS-iPSC-070-02) from a patient with neurodegeneration with brain iron accumulation (NBIA) having compound heterozygous mutations in PANK2 gene 2021 ·Stem Cell Research ·(unknown), Chun‐Hwei Tai, Han‐Yi Lin, Cheng‐Yen Huang, Chin‐Hsien Lin	1
9	Lack of RAB39B mutations in early-onset and familial Parkinson's disease in a Taiwanese cohort 2016 ·Neurobiology of Aging ·(unknown), Ruey‐Meei Wu, (unknown), Meng‐Ling Chen, Chun‐Hwei Tai, Chin‐Hsien Lin	8
10	The impact of nonmotor symptoms on quality of life in patients with Parkinson's disease in Taiwan 2015 ·Neuropsychiatric Disease and Treatment ·(unknown), Ruey‐Meei Wu, Chin‐Hsien Lin, Chun‐Hwei Tai, Rwei‐Ling Yu, (unknown)	33
11	Neuropsychological profile in patients with early stage of Parkinson's disease in Taiwan 2012 ·Parkinsonism & Related Disorders ·Rwei‐Ling Yu, Ruey‐Meei Wu, Chun‐Hwei Tai, Chin‐Hsien Lin, (unknown), Mau‐Sun Hua	42
12	Novel variant Pro143Ala in HTRA2 contributes to Parkinson’s disease by inducing hyperphosphorylation of HTRA2 protein in mitochondria 2011 ·Human Genetics ·Chin‐Hsien Lin, Meng‐Ling Chen, Grace Shiahuy Chen, Chun‐Hwei Tai, Ruey‐Meei Wu	45
13	Lrrk2 S1647T and BDNF V66M interact with environmental factors to increase risk of Parkinson’s disease 2010 ·Parkinsonism & Related Disorders ·Chin‐Hsien Lin, Ruey‐Meei Wu, Chun‐Hwei Tai, Meng‐Ling Chen, Fu‐Chang Hu	34
14	Feeling‐of‐knowing in episodic memory in patients with Parkinson's disease with various motor symptoms 2010 ·Movement Disorders ·Rwei‐Ling Yu, Ruey‐Meei Wu, Chun‐Hwei Tai, Chin‐Hsien Lin, Mau‐Sun Hua	19
15	Deep brain stimulation therapy for Parkinson’s disease using frameless stereotaxy: comparison with frame‐based surgery 2010 ·European Journal of Neurology ·Chun‐Hwei Tai, Ruey‐Meei Wu, Chin‐Hsien Lin, Ming‐Kai Pan, Ya‐Fang Chen, Hon‐Man Liu, Hsueh‐Ju Lu, Chia-Wen Tsai, (unknown)	24
16	Non-synonymous GIGYF2 variants in Parkinson’s disease from two Asian populations 2009 ·Human Genetics ·Eng‐King Tan, (unknown), Chun‐Hwei Tai, Louis C.S. Tan, Meng‐Ling Chen, (unknown), (unknown), Pavanni Ratnagopal, Yuen Yih, K.M. Prakash, Yi Zhao, Ruey‐Meei Wu	16
17	Intrapallidal injection of 6-hydroxydopamine induced changes in dopamine innervation and neuronal activity of globus pallidus 2009 ·Neuroscience ·Rabia Bouali‐Benazzouz, Chun‐Hwei Tai, (unknown), Abdelhamid Benazzouz	20
18	LRRK2 mutation in familial Parkinson’s disease in a Taiwanese population: clinical, PET, and functional studies 2008 ·Journal of Biomedical Science ·Chin‐Hsien Lin, Kai‐Yuan Tzen, (unknown), Chun‐Hwei Tai, Matthew J. Farrer, Ruey‐Meei Wu	45
19	Lack of mutations in spinocerebellar ataxia type 2 and 3 genes in a Taiwanese (ethnic Chinese) cohort of familial and early‐onset parkinsonism 2007 ·American Journal of Medical Genetics Part B Neuropsychiatric Genetics ·Chin‐Hsien Lin, Wuh‐Liang Hwu, Shu‐Chuan Chiang, Chun‐Hwei Tai, Ruey‐Meei Wu	8
20	Clinical, ¹⁸F‐dopa PET, and genetic analysis of an ethnic Chinese kindred with early‐onset parkinsonism and parkin gene mutations 2002 ·Movement Disorders ·Ruey‐Meei Wu, Din‐E Shan, Chenming Sun, Ren‐Shyan Liu, Wuh‐Liang Hwu, Chun‐Hwei Tai, Jennifer Hussey, Andrew B. West, Katrina Gwinn, John Hardy, Judy Chen, Matthew J. Farrer, Sarah Lincoln	26

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact